Tumor regulatory T cells potently abrogate antitumor immunity

Journal of Immunology

Volumn 182, Issue 10, 2009, Pages 6160-6167

  Liu, Zuqiang ^a   Kim, Jin H ^a   Falo Jr , Louis D ^a,b   You, Zhaoyang ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ADOPTIVE TRANSFER; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; LYMPHOCYTE ACTIVATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, REGULATORY;

EID: 77952391928     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802664     Document Type: Article

References (52)

1. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
2. Zou, W. 2006. Regulatory T cells, tumor immunity and immunotherapy. Nat. Rev. Immunol. 6: 295-307.
3. Munn, D. H., and A. L. Mellor. 2006. The tumor-draining lymph node as an immune-privileged site. Immunol. Rev. 213: 146-158.
4. Knutson, K. L., M. L. Disis, and L. G. Salazar. 2007. CD4 regulatory T cells in human cancer pathogenesis. Cancer Immunol. Immunother. 56: 271-285. (Pubitemid 46035899)
5. Curiel, T. J. 2008. Regulatory T cells and treatment of cancer. Curr. Opin. Immunol. 20: 241-246.
6. Turk, M. J., J. A. Guevara-Patiño, G. A. Rizzuto, M. E. Engelhorn, S. Sakaguchi, and N. Houghton. 2004. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J. Exp. Med. 200: 771-782.
7. Lutsiak, C. M. E., Y. Tagaya, A. J. Adams, J. Schlom, and H. Sabzevari. 2008. Tumor-induced impairment of TCR signaling results in compromised functionality of tumor-infiltrating regulatory T cells. J. Immunol. 180: 5871-5881.
8. Webster, W. S., R. H. Thompson, K. J. Harris, X. Frigola, S. Kuntz, B. A. Inman, and H. Dong. 2007. Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine. J. Immunol. 179: 2860-2869.
9. - T cells. J. Immunol. 178: 4051-4061.
10. + regulatory T cells in the peripheral blood of patients with prostate cancer. Clin. Cancer Res. 14: 1032-1040.
11. Chaput, N., G. Darrasse-Jèze, A. S. Bergot, C. Cordier, S. Ngo-Abdalla, D. Klatzmann, and O. Azogui. 2007. Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 Th cells at tumor sites. J. Immunol. 179: 4969-4978.
12. Liyanage, U. K., T. T. Moore, H. G. Joo, Y. Tanaka, V. Herrmann, G. Doherty, J. A. Drebin, S. M. Strasberg, T. J. Eberlein, P. S. Goedegebuure, and D. C. Linehan. 2002. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169: 2756-2761.
13. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
14. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
15. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6: 338-344.
16. + regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9: 239-244.
17. Vignali, D. A. A., L.W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
18. + Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer. J. Clin. Invest. 118: 3751-3761.
19. Cao, X., S. F. Cai, T. A. Fehniger, J. Song, L. I. Collins, D. R. Piwnica-Worms, and T. J. Ley. 2007. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27: 635-646. (Pubitemid 47628832)
20. Sarris, M., K. G. Andersen, F. Randow, L. Mayr, and A. G. Betz. 2008. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28: 402-413.
21. Liang, B., C. Workman, J. Lee, C. Chew, B. M. Dale, L. Colonna, M. Flores, N. Li, E. Schweighoffer, S. Greenberg, et al. 2008. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J. Immunol. 180: 5916-5926.
22. + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 105: 10113-10118.
23. + T cells. Nat. Immunol. 8: 1353-1362.
24. + Regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29: 771-781.
25. + responder cells by Fas-mediated apoptosis. J. Immunol. 182: 1469-1480.
26. + T cells. J. Immunol. 181: 4363-4370.
27. Kim, J. H., N. Majumder, H. Lin, J. Chen, L. D. Falo, Jr., and Z. You. 2005. Enhanced immunity by NeuEDhsp70 DNA vaccine is needed to combat an aggressive spontaneous metastatic breast cancer. Mol. Ther. 11: 941-949.
28. - lymphocytes is thymus and proliferation independent. Cancer Res. 66: 4488-4495.
29. + regulatory T cells down-regulate co-stimulatory molecules on antigen presenting cells. Eur. J. Immunol. 30: 1538-1543.
30. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172: 4676-4680.
31. high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J. Immunol. 176: 5293-5298.
32. + T cells. J. Immunol. 176: 6202-6210.
33. Tang, Q., J. Y. Adams, A. J. Tooley, M. Bi, B. T. Fife, P. Serra, P. Santamaria, R. M. Locksley, M. F. Krummel, and J. A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7: 83-92. (Pubitemid 41823872)
34. + T cells and dendritic cells in vivo. J. Exp. Med. 203: 505-511.
35. + regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10. Cancer Immunol. Immunother. 56: 48-59.
36. + regulatory T cells. J. Immunol. 178: 4184-4193.
37. + regulatory T cells: Role of B7-H3 expression and antigen presentation. Eur. J. Immunol. 37: 2117-2126.
38. Hänig, J., and M. B. Lutz. 2008. Suppression of mature dendritic cell function by regulatory T cells in vivo is abrogated by CD40 licensing. J. Immunol. 180: 1405-1413.
39. + regulatory T cell function. Science 322: 271-275.
40. Hiura, T., H. Kagamu, S. Miura, A. Ishida, H. Tanaka, J. Tanaka, F. Gejyo, and H. Yoshizawa. 2005. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression. J. Immunol. 175: 5058-5066. (Pubitemid 41456389)
41. Bui, J. D., R. Uppaluri, C. S. Hsieh, and R. D. Schreiber. 2006. Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins. Cancer Res. 66: 7301-7309.
42. Sharma, M. D., B. Baban, P. Chandler, D. Y. Hou, N. Singh, H. Yagita, M. Azuma, B. R. Blazar, A. L. Mellor, and D. H. Munn. 2007. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2, 3-dioxygenase. J. Clin. Invest. 117: 2570-2582.
43. + T cell suppressor function. J. Immunol. 172: 6519-6523.
44. + regulatory T cells. Eur. J. Immunol. 38: 1643-1653.
45. Klein, L., K. Khazaie, and H. von Boehmer. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100: 8886-8889. (Pubitemid 36899193)
46. Oliveira, V., B. Sawitzki, S. Chapman, C. Appelt, I. Gebuhr, J. Wieckiewicz, E. Long, and K. J. Wood. 2008. Anti-CD4-mediated selection of Treg in vitro: in vitro suppression does not predict in vivo capacity to prevent graft rejection. Eur. J. Immunol. 38: 1677-1688.
47. + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner. J. Exp. Med. 202: 1075-1085.
48. + T helper cells and hindered by naturally occurring T regulatory cells. J. Immunol. 174: 2591-2601.
49. + cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J. Exp. Med. 201: 779-791.
50. + T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model. J. Immunol. 178: 6840-6848.
51. Siegmund, K., M. Feuerer, C. Siewert, S. Ghani, U. Haubold, A. Dankof, V. Krenn, M. P. Schön, A. Scheffold, J. B. Lowe, et al. 2005. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106: 3097-3104. (Pubitemid 41565906)
52. + T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment. Clin. Cancer Res. 13: 4345-4354.